X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7540) 7540
Newsletter (85) 85
Book Chapter (36) 36
Magazine Article (11) 11
Dissertation (9) 9
Web Resource (4) 4
Publication (3) 3
Newspaper Article (2) 2
Report (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6642) 6642
female (3856) 3856
male (3721) 3721
azathioprine (3567) 3567
azathioprine - therapeutic use (3195) 3195
adult (3140) 3140
azathioprine - adverse effects (2795) 2795
middle aged (2525) 2525
immunosuppressive agents - therapeutic use (2297) 2297
immunosuppressive agents - adverse effects (2131) 2131
gastroenterology & hepatology (1308) 1308
aged (1234) 1234
drug therapy, combination (1202) 1202
treatment outcome (1166) 1166
adolescent (1150) 1150
therapy (1041) 1041
azathioprine - administration & dosage (1023) 1023
transplantation (993) 993
kidney transplantation (972) 972
surgery (878) 878
retrospective studies (822) 822
inflammatory-bowel-disease (807) 807
immunosuppressive agents - administration & dosage (764) 764
crohn disease - drug therapy (744) 744
child (743) 743
6-mercaptopurine (722) 722
follow-up studies (713) 713
time factors (704) 704
prednisone - therapeutic use (688) 688
immunosuppression (663) 663
cyclosporine - therapeutic use (661) 661
immunology (653) 653
pharmacology & pharmacy (638) 638
risk factors (611) 611
crohns-disease (601) 601
inflammatory bowel disease (600) 600
infliximab (580) 580
crohn's disease (575) 575
cyclosporine (552) 552
inflammatory bowel diseases - drug therapy (544) 544
methotrexate (503) 503
cyclosporine - adverse effects (501) 501
young adult (487) 487
care and treatment (476) 476
medicine, general & internal (475) 475
mycophenolic acid - analogs & derivatives (475) 475
colitis, ulcerative - drug therapy (453) 453
prospective studies (441) 441
mycophenolic acid - therapeutic use (437) 437
mercaptopurine - therapeutic use (435) 435
ulcerative colitis (429) 429
corticosteroids (419) 419
cyclophosphamide - therapeutic use (419) 419
drug therapy (415) 415
methotrexate - therapeutic use (415) 415
rheumatology (409) 409
prednisolone - therapeutic use (402) 402
mercaptopurine - adverse effects (396) 396
immunosuppressive agents (390) 390
prednisone - adverse effects (388) 388
animals (387) 387
pharmacogenetics (386) 386
adrenal cortex hormones - therapeutic use (385) 385
patients (382) 382
mycophenolate-mofetil (375) 375
mycophenolate mofetil (374) 374
cyclophosphamide (368) 368
management (364) 364
double-blind (362) 362
transplantation, homologous (358) 358
dermatology (357) 357
kidney transplantation - immunology (357) 357
recurrence (355) 355
pregnancy (350) 350
efficacy (344) 344
medicine & public health (344) 344
remission induction (341) 341
remission (332) 332
disease (329) 329
cyclosporins - adverse effects (322) 322
health aspects (315) 315
child, preschool (314) 314
dose-response relationship, drug (308) 308
glucocorticoids - therapeutic use (298) 298
antibodies, monoclonal - therapeutic use (297) 297
anti-inflammatory agents - therapeutic use (295) 295
cyclophosphamide - adverse effects (292) 292
mercaptopurine (290) 290
research (290) 290
prognosis (289) 289
toxicity (287) 287
children (283) 283
prednisone (283) 283
risk (282) 282
biopsy (280) 280
prednisone - administration & dosage (280) 280
immunosuppression - adverse effects (279) 279
long-term (277) 277
analysis (276) 276
graft rejection - prevention & control (276) 276
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6978) 6978
German (290) 290
French (148) 148
Spanish (119) 119
Japanese (57) 57
Portuguese (32) 32
Italian (27) 27
Russian (25) 25
Polish (24) 24
Danish (17) 17
Korean (15) 15
Hungarian (12) 12
Dutch (9) 9
Czech (8) 8
Chinese (5) 5
Hebrew (4) 4
Norwegian (4) 4
Croatian (3) 3
Finnish (3) 3
Swedish (3) 3
Bulgarian (2) 2
Lithuanian (2) 2
Slovak (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 6, p. e0198184
Background Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 2, pp. 380 - 388.e4
Journal Article
Drug safety, ISSN 0114-5916, 2000, Volume 23, Issue 5, pp. 429 - 448
...).Sulfasalazine consists of sulfapyridine linked to 5-aminosalicylic acid (5-ASA) via an azo bond. Common adverse effects related to sulfapyridine intolerance include headache, nausea, anorexia, and malaise... 
Mercaptopurine, general | Inflammatory bowel disease, treatment | Salicylates, general | Ciprofloxacin, general | Cyclosporin, general | Sulfasalazine, general | Azathioprine, general | Antibacterials, general | Metronidazole, general | Methotrexate, general | Tacrolimus, general | Immunomodulators, general | Mycophenolate mofetil, general | Aminosalicylic acid, general | Corticosteroids, general | RHEUMATOID-ARTHRITIS | LONG-TERM | RENAL-ALLOGRAFT RECIPIENTS | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | ACTIVE CROHNS-DISEASE | RESISTANT ULCERATIVE-COLITIS | 5-AMINOSALICYLIC ACID | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TOXICOLOGY | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Anti-Infective Agents - pharmacology | Humans | Immunosuppressive Agents - therapeutic use | Male | Sulfasalazine - pharmacology | Adrenal Cortex Hormones - therapeutic use | Prodrugs - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Female | Immunosuppressive Agents - pharmacology | Inflammatory Bowel Diseases - drug therapy | Sulfasalazine - therapeutic use | Anti-Infective Agents - adverse effects | Mesalamine - adverse effects | Adrenal Cortex Hormones - pharmacology | Anti-Infective Agents - therapeutic use | Pregnancy | Adrenal Cortex Hormones - adverse effects | Gastrointestinal Agents - pharmacology | Mesalamine - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Gastrointestinal Agents - therapeutic use | Mesalamine - therapeutic use | Immunosuppressive Agents - adverse effects | Gastrointestinal Agents - adverse effects | Sulfasalazine - adverse effects
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 03/2017, Volume 2017, Issue 10, p. CD011639
Background As part of liver transplantation, immunosuppression (suppressing the host immunity) is given to prevent graft rejections resulting from the immune... 
Liver Transplantation | LIVER TRANSPLANTATION AND RELATED SURGERY (KJJC) (ACCORDING TO NCSP) | Immunosuppressive Agents | Glucocorticoids | Sirolimus | Gastroenterology & hepatology | Liver disorders | Transplantation | Cyclosporine | Mycophenolic Acid | Retreatment | Immunosuppression | Tacrolimus | Maintenance immunosuppression | Bayes Theorem | Transplantation Immunology | Network Meta‐Analysis | Azathioprine | Drug Therapy, Combination | Odds Ratio | Medicine General & Introductory Medical Sciences | Everolimus | TRANSPLANTATION: SOLID ORGAN | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Immunosuppression - methods | Humans | Immunosuppressive Agents - therapeutic use | Immunosuppression - mortality | Immunosuppression - adverse effects | Everolimus - adverse effects | Adult | Everolimus - therapeutic use | Network Meta-Analysis | Glucocorticoids - adverse effects | Sirolimus - adverse effects | Sirolimus - therapeutic use | Liver Transplantation - mortality | Retreatment - statistics & numerical data | Tacrolimus - adverse effects | Cyclosporine - therapeutic use | Mycophenolic Acid - adverse effects | Tacrolimus - therapeutic use | Drug Therapy, Combination - mortality | Mycophenolic Acid - therapeutic use | Cyclosporine - adverse effects | Immunosuppressive Agents - adverse effects | Azathioprine - adverse effects
Journal Article
The American journal of gastroenterology, ISSN 0002-9270, 10/2009, Volume 104, Issue 10, pp. 2524 - 2533
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2020, Issue 3, p. CD000545
Background The results from controlled clinical trials investigating the efficacy of azathioprine and 6‐mercaptopurine for the treatment of active Crohn's... 
Mesalamine | Immunosuppressive Agents | Glucocorticoids | Gastroenterology & hepatology | Azathioprine or 6‐mercaptopurine therapy | Crohn Disease | Induction Chemotherapy | Prednisone | Withholding Treatment | Antimetabolites | Randomized Controlled Trials as Topic | Crohn's disease: induction of remission | Inflammatory bowel disease | CROHN'S DISEASE ‐ INDUCTION OF REMISSION | Infliximab | Sulfasalazine | Azathioprine | Medicine General & Introductory Medical Sciences | Mercaptopurine | LONG-TERM | CLINICAL-PHARMACOLOGY | Induction Chemotherapy [methods] | Humans | 6-Mercaptopurine [adverse effects; therapeutic use] | RANDOMIZED-TRIAL | EARLY COMBINED IMMUNOSUPPRESSION | Immunosuppressive Agents [adverse effects; therapeutic use] | INFLIXIMAB PLUS AZATHIOPRINE | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | THERAPY | Crohn Disease [drug therapy] | DOUBLE-BLIND TRIAL | TERM-FOLLOW-UP | Azathioprine [adverse effects; therapeutic use] | MYCOPHENOLATE-MOFETIL | Sulfasalazine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - administration & dosage | Prednisone - administration & dosage | Immunosuppressive Agents - therapeutic use | Induction Chemotherapy - methods | Mercaptopurine - adverse effects | Antimetabolites - therapeutic use | Infliximab - therapeutic use | Antimetabolites - adverse effects | Mercaptopurine - therapeutic use | Crohn Disease - drug therapy | Mesalamine - therapeutic use | Adult | Immunosuppressive Agents - adverse effects | Induction Chemotherapy - statistics & numerical data | Azathioprine - adverse effects
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 20, pp. 1886 - 1895
Journal Article